Authors:
Bergthorsson, JT
Ejlertsen, B
Olsen, JH
Borg, A
Nielsen, KV
Barkardottir, RB
Klausen, S
Mouridsen, HT
Winther, K
Fenger, K
Niebuhr, A
Harboe, TL
Niebuhr, E
Citation: Jt. Bergthorsson et al., BRCA1 and BRCA2 mutation status and cancer family history of Danish women affected with multifocal or bilateral breast cancer at a young age, J MED GENET, 38(6), 2001, pp. 361-368
Authors:
Melbye, M
Wohlfahrt, J
Lei, U
Norgaard-Pedersen, B
Mouridsen, HT
Lambe, M
Michels, KB
Citation: M. Melbye et al., alpha-fetoprotein levels in maternal serum during pregnancy and maternal breast cancer incidence, J NAT CANC, 92(12), 2000, pp. 1001-1005
Authors:
Kroman, N
Jensen, MB
Wohlfahrt, J
Mouridsen, HT
Andersen, PK
Melbye, M
Citation: N. Kroman et al., Factors influencing the effect of age on prognosis in breast cancer: population based study, BR MED J, 320(7233), 2000, pp. 474-478
Authors:
Rostgaard, K
Holst, H
Mouridsen, HT
Lynge, E
Citation: K. Rostgaard et al., Do clinical databases render population-based cancer registers obsolete? The example of breast cancer in Denmark, CANC CAUSE, 11(7), 2000, pp. 669-674
Authors:
Kroman, N
Thorpe, SM
Wohlfahrt, J
Andersen, KW
Mouridsen, HT
Citation: N. Kroman et al., Variations in prognostic factors in primary breast cancer throughout the menstrual cycle, EUR J SUR O, 26(1), 2000, pp. 11-16
Authors:
Axelsson, CK
Rank, F
Blichert-Toft, M
Mouridsen, HT
Jensen, MB
Citation: Ck. Axelsson et al., Impact of axillary dissection on staging and regional control in breast tumors <= 10 mm - The DBCG experience, ACTA ONCOL, 39(3), 2000, pp. 283-289
Authors:
Rose, C
Kamby, C
Mouridsen, HT
Andersson, M
Bastholt, L
Moller, KA
Andersen, J
Munkholm, P
Dombernowsky, P
Christensen, IJ
Citation: C. Rose et al., Combined endocrine treatment of elderly postmenopausal patients with metastatic breast cancer - A randomized trial of tamoxifen vs. tamoxifen plus aminoglutethimide and hydrocortisone and tamoxifen plus fluoxymesterone in women above 65 years of age, BREAST CANC, 61(2), 2000, pp. 103-110
Authors:
Pedersen, AN
Christensen, IJ
Stephens, RW
Briand, P
Mouridsen, HT
Dano, K
Brunner, N
Citation: An. Pedersen et al., The complex between urokinase and its type-1 inhibitor in primary breast cancer: Relation to survival, CANCER RES, 60(24), 2000, pp. 6927-6934
Authors:
Andersson, M
Madsen, EL
Overgaard, M
Rose, C
Dombernowsky, P
Mouridsen, HT
Citation: M. Andersson et al., Doxorubicin versus methotrexate both combined with cyclophosphamide, 5-fluorouracil and tamoxifen in postmenopausal patients with advanced breast cancer - a randomised study with more than 10 years follow-up from the Danish Breast Cancer Cooperative Group, EUR J CANC, 35(1), 1999, pp. 39-46
Authors:
Kristensen, B
Ejlertsen, B
Groenvold, M
Hein, S
Loft, H
Mouridsen, HT
Citation: B. Kristensen et al., Oral clodronate in breast cancer patients with bone metastases: a randomized study, J INTERN M, 246(1), 1999, pp. 67-74
Authors:
Groenvold, M
Fayers, PM
Sprangers, MAG
Bjorner, JB
Klee, MC
Aaronson, NK
Bech, P
Mouridsen, HT
Citation: M. Groenvold et al., Anxiety and depression in breast cancer patients at low risk of recurrencecompared with the general population: A valid comparison?, J CLIN EPID, 52(6), 1999, pp. 523-530
Authors:
Pedersen, L
Holck, S
Mouridsen, HT
Schiodt, T
Zedeler, K
Citation: L. Pedersen et al., Prognostic comparison of three classifications for medullary carcinoma of the breast, HISTOPATHOL, 34(2), 1999, pp. 175-175
Authors:
Overgaard, M
Jensen, MB
Overgaard, J
Hansen, PS
Rose, C
Andersson, M
Kamby, C
Kjaer, M
Gadeberg, CC
Rasmussen, BB
Blichert-Toft, M
Mouridsen, HT
Citation: M. Overgaard et al., Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial, LANCET, 353(9165), 1999, pp. 1641-1648